GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
83 hedge funds and large institutions have $39.8M invested in GALENA BIOPHARMA INC COM in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
50% more call options, than puts
Call options by funds: $4.78M | Put options by funds: $3.18M
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
6% more funds holding
Funds holding: 78 → 83 (+5)
6% less capital invested
Capital invested by funds: $42.3M → $39.8M (-$2.47M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$293K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$176K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$129K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$124K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$376K |
| 2 |
Morgan Stanley
New York
|
-$212K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$108K |
| 4 |
Goldman Sachs
New York
|
-$90.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$67K |
RXII Hedge Fund Activity: Q4 2015 in Review
83 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2015, worth a combined $39.8M — down 5.8% from $42.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RXII positions and 6 closed out — a net gain of 5 holders — while 28 added to existing stakes and 22 trimmed.
The largest buyer was State Street, adding an estimated $293K. The largest seller was Susquehanna International Group, cutting an estimated $376K.
- 83 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2015, up from 78 in Q3 2015.
- Funds reported $39.8M of GALENA BIOPHARMA INC COM stock for Q4 2015, down 5.8% quarter-over-quarter.
- 11 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2015 and 6 closed out, a net change of +5 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q4 2015 was State Street, an estimated $293K added.
- The largest GALENA BIOPHARMA INC COM seller in Q4 2015 was Susquehanna International Group, an estimated $376K sold.
Based on aggregated 13F filings for Q4 2015.